Article Per Year (5 Year)
p-Index From 2020 - 2025
0.983
P-Index
This Author published in this journals
All Journal Journal Of World Science Acta Medical and Health Sciences (AMHS) Sahabat Sosial: Jurnal Pengabdian Masyarakat
Pujowaskito, Prihati
Unknown Affiliation
Humanities Biochemistry, Genetics & Molecular Biology Computer Science & IT Economics, Econometrics & Finance Education Engineering Health Professions Immunology & microbiology Law, Crime, Criminology & Criminal Justice Medicine & Pharmacology Nursing Public Health Social Sciences

Published : 5 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 5 Documents
Search

 1 
Pemeriksaan Kadar Glukosa, Asam Urat dan Kolesterol Universitas Pertahanan RI Di Muara Angke Ibrizatun, Amin; Pujowaskito, Prihati; Wibowo, Markus; Yochannan, Elisa; Pannyiwi, Rahmat; Sipahutar, Pongki; Wijayanti, Azmi; Wahyudin, Ferdic Sukma; Sofiana, Sofiana
Sahabat Sosial: Jurnal Pengabdian Masyarakat Vol. 2 No. 4 (2024): Sahabat Sosial: Jurnal Pengabdian Masyarakat (September)
Publisher : Asosiasi Guru dan Dosen Seluruh Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59585/sosisabdimas.v2i4.484

Abstract

The Ministry of Health stated that non-communicable diseases cause high mortality rates each year and can infect individuals of all ages and countries around the world. Non-communicable diseases include heart disease, diabetes mellitus and kidney disease. To overcome these health problems, preventive measures are needed that aim to improve the quality of life of the nation. This is stated in the Presidential Instruction which is one part of the meaning of Germas, namely routine health checks that are useful for facilitating early detection of diseases or health problems. The examinations carried out are divided into 2, namely examination of random blood sugar levels, uric acid, and cholesterol levels and EKG (Electrocardiography) examinations. The purpose of community service is to provide information on the results of examinations of random blood sugar levels, uric acid, and cholesterol levels by the PkM TEAM from Lecturers together with Cadets of the Indonesian Defense University for the people of Muare Angke in improving health. The method is by examining random blood sugar levels, uric acid and cholesterol. The results concluded that most respondents had normal blood sugar levels, uric acid levels, and cholesterol levels.
Pemberian Suplemen Makanan Fituno Kimia Farma dalam Membantu Menjaga Daya Tahan Tubuh Bagi Sumber Daya Manusia (SDM) Fakultas Kedokteran dan Ilmu Kesehatan Universitas Pertahanan RI Pujowaskito, Prihati; Ibrizatun, Amin; T.W, Lila Irawati; Yochanan, E.; Rahman, Arief; Pannyiwi, Rahmat
Sahabat Sosial: Jurnal Pengabdian Masyarakat Vol. 2 No. 4 (2024): Sahabat Sosial: Jurnal Pengabdian Masyarakat (September)
Publisher : Asosiasi Guru dan Dosen Seluruh Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59585/sosisabdimas.v2i4.491

Abstract

Indonesia has a big challenge to face currently, namely health problems. Three important health problems include the increase in non-communicable diseases, infectious diseases and the emergence of diseases that should have been successfully overcome. One model for maintaining health problems and/or a healthy immune system is by adopting a nutritious food and drink pattern. There are several foods and drinks that can strengthen the immune system, one of which contains Echinaceae, Morindae, Pylarthi, Vitamin B1 HCL, Vitamin B6 HCL, Vitamin E. Therefore, it is very important to consume Kimia Farma's Fituno Food Supplement to help maintain the body's immune system regularly. As an effort to increase endurance for Human Resources of the Faculty of Medicine and Health Sciences, Defense University of the Republic of Indonesia in carrying out daily activities. The implementation method used in this activity includes providing Fituno Kimia Farma Food Supplements. The results of this activity are related to efforts to increase body endurance through regular consumption of Fituno Kimia Farma Food Supplement products in collaboration with the Faculty of Medicine and Health Sciences through the Dean, Dr. Dr. Prihati Pujowaskito, Sp.JP (K)., FIHA., M.M.R.S. Our hope for the future is that the Fituno Kimia Farma Food Supplement will continue to meet the human resource needs of the Faculty of Medicine and Health Sciences, Defense University of the Republic of Indonesia.
Stem Cell Therapy for Men’s Vitality in Supporting National Health and Defense: A Comprehensive Review and Meta-Analysis Vinski, Deby Susanti Pada; Trofimova, Svetlana; Pujowaskito, Prihati; Wibowo, Markus; Vinski, Natasha Cinta
Journal of World Science Vol. 4 No. 3 (2025): Journal of World Science
Publisher : Riviera Publishing

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58344/jws.v4i3.1317

Abstract

This comprehensive review and meta-analysis examines the efficacy of stem cell therapy in enhancing men’s vitality while supporting national health and defense systems. Patient care records served as the primary source of data for evaluation and analysis, ensuring that real-world clinical outcomes were robustly captured. The study also evaluated the quality assurance of stem cell products cultured by the integrated Celltech Stem Cell Centre Laboratory and Banking, affirming that these products meet stringent clinical standards. Findings indicate that stem cell therapy possesses significant regenerative potential, particularly in repairing damaged cells. Notably, several patients who underwent therapy at the Celltech Stem Cell Center experienced remarkable functional recovery. These results underscore the therapeutic promise of stem cells not only for individual patient recovery but also as a strategic component in enhancing overall public health and national defense readiness.
Cardiac damage in an adolescent patient with COVID-19: a case report Pujowaskito, Prihati; Tartila, Tamia S; Tafriend, Novaro A; Jannah, Fatimah D K; Mayasari, Elsy
ACTA Medical Health Sciences Vol. 1 No. 2 (2022): ACTA Medical Health Sciences
Publisher : ACTA Medical Health Sciences

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (513.812 KB)

Abstract

COVID-19 has been found to affect the cardiovascular system leading to myocardial damage. A study of 41 patients in Wuhan, China, found that 12% of COVID-19 patients experienced virus-related acute cardiac damage.Subsequent bigger Chinese studies also found acute cardiac damage in 7.2% to 27.8% of hospitalized patients. As a chronicsequela, this condition may result in cardiomyopathy. We report acase of an adolescent COVID-19 survivor with dilated cardiomyopathy with no underlying heart disease. A male patient aged 16 years old was admitted to our outpatient clinic with the primary symptom of exhaustion and had recovered frommild to moderate COVID-19 one month prior to the visit. No previous history of heart disease was documented. Physical examination showed no abnormalities. Laboratory results revealed substantially elevated NT-proBNP (7705 pg/mL) and D-dimer (1850 ng/mL). ECG presented normal sinus rhythm with poorR wave progression. Echocardiography revealed all chamber dilatation, eccentric left ventricular hypertrophy, globalhypokinetic, moderate mitral regurgitation, and reduced ejection fraction (22%). We diagnosed the patient with new-onset dilated cardiomyopathy and began treatment with candesartan, bisoprolol, furosemide, spironolactone, rivaroxaban, and trimetazidine. The recovery was steady at three-month follow-up visit. The emergence of new-onset cardiomyopathy in this previously healthy adolescent raisesthepossibility of COVID-19 acting asthe sole cause of myocardial injuryin the absence of underlying heart disease. To avoid further complications, comprehensive evaluation and effective therapy should be implemented during hospitalization and post-discharge. Additional tests such as cardiac magnetic resonance imaging and endomyocardial biopsies shouldbe performed to support final proof. DOI : 10.35990/amhs.v1n2.p88-96 REFERENCES Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. https://doi.org/10.1016/S0140-6736(20)30183-5 World Health Organization. COVID-19 weekly epidemiological update [updated 22 March 2022; cited 22 March 2022]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20220322_weekly_epi_update_84.pdf?sfvrsn=9ec904fc_4&download=true Tosepu R, Effendy DS, Ahmad LOAI. The first confirmed cases of COVID-19 in Indonesian citizens. Public Health of Indonesia. 2020;6(2):70–71. https://doi.org/10.36685/phi.v6i2.337 Indonesian Ministry of Health. COVID-19 situation in Indonesia [updated 22 March 2022; cited 22 March 2022]. Available from: https://covid19.go.id/artikel/2022/03/22/situasi-covid-19-di-indonesia-pdate-22-maret-2022 Mesquita RR, Junior LCFS, Santana FMS, Oliveira TF, Alcantara RC, Arnozo GM, et al. Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr. 2021;133:377–382. https://doi.org/10.1007/s00508-020-01760-4 Hendren NS, Drazner MH, Bozkurt B, Cooper LT. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation. 2020;141(23):1903–1914. https://doi.org/10.1161/CIRCULATIONAHA.120.047349 Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. https://doi.org/10.1001/jama.2020.1585 Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802–810. https://doi.org/10.1001/jamacardio.2020.0950 Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–818. https://doi.org/10.1001/jamacardio.2020.1017 Zaman S, MacIsaac AI, Jennings GLR, Schlaich MP, Inglis SC, Arnold R, et al. Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement. Med J Aust. 2020;213(4):182–187. https://doi.org/10.5694/mja2.50714 Limongelli G, Crotti L. COVID-19 pandemia and inherited cardiomyopathies and channelopathies: a short-term and long-term perspective. Orphanet J Rare Dis. 2020;15:157. https://doi.org/10.1186/s13023-020-01444-2 Fried JA, Ramasubbu K, Bhatt R, Topkara VK, Clerkin KJ, Horn E, et al. The variety of cardiovascular presentations of COVID-19. Circulation. 2020;141:1930–1936. https://doi.org/10.1161/CIRCULATIONAHA.120.047164 Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75:2352–2371. https://doi.org/10.1016/j.jacc.2020.03.031 Schilling JD, Ravichandran AK, Mandras SA. Management of the hospitalized COVID-19 patient with acute cardiomyopathy or heart failure [updated 16 April 2020; cited 23 March 2022]. Available from: https://www.acc.org/latest-in-cardiology/articles/2020/04/16/14/42/management-of-the-hospitalized-covid-19-coronavirus-2019-patient-with-acute-cardiomyopathy-or-heart-failure Kang Y, Chen T, Mui D, Ferrari V, Jagasia D, Scherrer-Crosbie M, et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106:1132–1141. http://dx.doi.org/10.1136/heartjnl-2020-317056 Sukmawan R. Cardiomyopathy in COVID-19 survivors: mechanism, management, and prevention. Indonesian J Cardiol. 2020;41:120–124. https://doi.org/10.30701/ijc.1012 Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012;366:619–628. https://doi.org/10.1056/nejmoa1110186 Pinamonti B, Abate E, de Luca A, Finocchiaro G, Korcova R. Role of cardiac imaging: echocardiography. In: Sinagra G, Merlo M, Pinamonti B, editors. Dilated cardiomyopathy: from genetics to clinical management. Cham (CH): Springer; 2019. https://doi.org/10.1007/978-3-030-13864-6_7 European Society of Cardiology. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1 – epidemiology, pathophysiology, and diagnosis. Eur Heart J. 2022;43:1033–1058. https://doi.org/10.1093/eurheartj/ehab696 Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24:422. https://doi.org/10.1186/s13054-020-03120-0 Yang G, Tan Z, Zhou L, Yang M, Peng L, Liu J, et al. Effects of angiotensin II receptor blockers and ACE inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: a single-center retrospective study. Hypertension. 2020;76(1):51–58. https://doi.org/10.1161/hypertensionaha.120.15143 COVID-19 RISk and Treatments (CORIST) Collaboration. RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies. Vascul Pharmacol. 2020;135:106805. https://doi.org/10.1016/j.vph.2020.106805 European Society of Cardiology. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2 – care pathways, treatment, and follow-up. Eur Heart J. 2022;43:1059–1103. https://doi.org/10.1093/eurheartj/ehab697 Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18:1094–1099. https://doi.org/10.1111/jth.14817 Ramacciotti E, Agati LB, Calderaro D, Aguiar VCR, Spyropoulos AC, de Oliveira CCC, et al. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial. Lancet. 2022;399:50–59. https://doi.org/10.1016/S0140-6736(21)02392-8 Al-kuraishy HM, Al-Gareeb AI, Welson NN, Batiha GES. Trimetazidine and COVID-19-induced acute cardiac injury: a missed key. Int J Clin Pharm. 2022;44:832–833. https://doi.org/10.1007/s11096-022-01408-5
From Vitality to Security: Stem Cells and Testosterone Supporting Health and National Defense with the Vinski Protocol Vinski, Deby Susanti Pada Vinski; Vinski, Natasha Cinta; Trofimova, Svetlana; Kurniawan Nugroho, Andi; Pujowaskito, Prihati
Journal of World Science Vol. 4 No. 11 (2025): Journal of World Science
Publisher : Riviera Publishing

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58344/jws.v4i11.1589

Abstract

The vitality and health of a nation’s citizens, especially its emergency and defense forces, are inseparable from national security. Regenerative and hormonal medicine is an exciting new field in performance medicine. This Phase 1 clinical trial assesses the safety and initial effectiveness of the Vinski Protocol, an innovative therapy involving umbilical cord-derived mesenchymal stem cells (UC-MSCs) in conjunction with testosterone optimization therapy. Twenty-five healthy men, aged 25-45 years, received three intravenous infusions of UC-MSCs and weekly testosterone cypionate for 12 weeks. Primary outcomes measured safety through adverse event monitoring and clinical laboratory profiles, and secondary outcomes were serum testosterone change, VO2 max, body composition, inflammatory markers (C-reactive protein [CRP] and interleukin 6 [IL-6]), and subjective vitality. The protocol was well-tolerated with no serious adverse events; 12% of subjects reported mild fatigue. Statistically significant changes were noted in testosterone level (+215 ng/dL, p < 0.01), lean mass (+2.1 kg, p < 0.05), VO2 max (+11.8%, p < 0.05), and decreases in CRP and IL-6 (p < 0.05). Energy and mental clarity also improved in subjects. These findings provide evidence for the feasibility and potential effectiveness of the Vinski Protocol as a dual regenerative-hormonal approach to increasing individual vitality and overall health resilience.
Co-Authors Arief Rahman Ferdic Sukma Wahyudin Ibrizatun, Amin Jannah, Fatimah D K Kurniawan Nugroho, Andi Markus Wibowo Mayasari, Elsy Pannyiwi, Rahmat Sipahutar, Pongki Sofiana Sofiana, Sofiana T.W, Lila Irawati Tafriend, Novaro A Tartila, Tamia S Trofimova, Svetlana Vinski, Deby Susanti Pada Vinski, Deby Susanti Pada Vinski Vinski, Natasha Cinta Wijayanti, Azmi Yochanan, E. Yochannan, Elisa